It is well appreciated that the pace and scale of investment in mental health R&D does not match the need. In this Wellcome*-commissioned study, Technopolis explored barriers and possible solutions to improving this leaky pipeline. Looking across four country contexts, and focusing on depression, anxiety and psychosis, they identified 12 scientific and 10 non-scientific barriers in the mental health R&D ecosystem. 

We encourage you to read the paper for a deep dive on these, but want to highlight the three recommendations for future actions, which fully align with IAMHRF’s mission and ongoing activities:

  • Funding to encourage and enable innovation through financial support for educational activities, research programmes, and infrastructure development to drive innovation and accessibility in mental health research.
  • Convening to catalyse collaborations by bringing stakeholders together to launch campaigns, workshops, and regulatory discussions, fostering collaboration and best practice sharing.
  • Advocating and influencing to drive change in the research funding landscape, policy and regulatory context of mental health interventions, and for the meaningful involvement of individuals with lived experience.

*IAMHRF Member